Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Giegling

Showing results (71-80 of 191) with videos related to

Pageof 20
Sort By:
Archives of General Psychiatry|September 3, 2008
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticismEdwin J C G van den Oord, Po-Hsiu Kuo, Annette M Hartmann, et al.
Schizophrenia Research|September 6, 2011
Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophreniaOlaoluwa Okusaga, Patricia Langenberg, Aamar Sleemi, et al.
Pharmacogenetics and Genomics|September 23, 2010
Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidolIna Giegling, Antonio Drago, Vita Dolžan, et al.
Neuromolecular Medicine|August 22, 2014
No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophreniaSarah Tosato, Martina Zanoni, Chiara Bonetto, et al.
Circulation. Cardiovascular Genetics|October 28, 2016
Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based CohortMaria Elena Lacruz, Alexander Kluttig, Daniel Tiller, et al.
Plos One|May 27, 2015
A genome-wide copy number variant study of suicidal behaviorJeffrey A Gross, Alexandre Bureau, Jordie Croteau, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 16, 2012
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidolIna Giegling, Beatrice Balzarro, Stefano Porcelli, et al.
Journal of Psychiatric Research|May 12, 2009
Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory taskSusanne Karch, Gregor Leicht, Ina Giegling, et al.
Pharmacogenomics|November 19, 2013
Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapineBenjamin W J Spencer, Barbara Prainsack, Dan Rujescu, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 7, 2005
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremensAndre Tadic, Norbert Dahmen, Armin Szegedi, et al.
Pageof 20

Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Archives of General Psychiatry|September 3, 2008
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticismEdwin J C G van den Oord, Po-Hsiu Kuo, Annette M Hartmann, et al.
Schizophrenia Research|September 6, 2011
Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophreniaOlaoluwa Okusaga, Patricia Langenberg, Aamar Sleemi, et al.
Pharmacogenetics and Genomics|September 23, 2010
Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidolIna Giegling, Antonio Drago, Vita Dolžan, et al.
Neuromolecular Medicine|August 22, 2014
No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophreniaSarah Tosato, Martina Zanoni, Chiara Bonetto, et al.
Circulation. Cardiovascular Genetics|October 28, 2016
Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based CohortMaria Elena Lacruz, Alexander Kluttig, Daniel Tiller, et al.
Plos One|May 27, 2015
A genome-wide copy number variant study of suicidal behaviorJeffrey A Gross, Alexandre Bureau, Jordie Croteau, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 16, 2012
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidolIna Giegling, Beatrice Balzarro, Stefano Porcelli, et al.
Journal of Psychiatric Research|May 12, 2009
Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory taskSusanne Karch, Gregor Leicht, Ina Giegling, et al.
Pharmacogenomics|November 19, 2013
Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapineBenjamin W J Spencer, Barbara Prainsack, Dan Rujescu, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 7, 2005
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremensAndre Tadic, Norbert Dahmen, Armin Szegedi, et al.
Pageof 20